Clinical Insights
Opinion
Studies reinforce clinical experience and intuition
Dr. Alan P. Lyss looks at the immune-related adverse events in patients on immune checkpoint inhibitors and the effect of delays in starting...
Opinion
Screening for pancreatic and lung cancers
Dr. Alan P. Lyss explores the complexity of shared decision-making in cancer screening.
Opinion
Immune checkpoint inhibitors and locally ablative therapy in NSCLC
Two trials raise important questions about the treatment of non-small cell lung cancer in the age of immuno-oncology, but the findings aren’t...
Opinion
Potential improvements in convenience, tolerability of hematologic treatment
Dr. Alan P. Lyss dissects the practice changing elements of the COLUMBA trial in multiple myeloma and the ASCEND trial in CLL.
Opinion
Predicting outcomes in acute leukemia, NSCLC
Dr. Alan Lyss examines the latest research on predicting VTE risk in patients with acute leukemia and new data on the impact of steroids in non–...
Article
Chemo-free neoadjuvant approaches emerge in NSCLC and breast cancer
Dr. Alan P. Lyss breaks down new data presented on immune checkpoint inhibitors in NSCLC and trastuzumab emtansine for HER2-positive breast cancer...
Opinion
NSCLC: Local consolidative therapy in oligometastatic disease and immunotherapy in EGFR mutations
Dr. Alan P. Lyss looks at two recent reports about treatment in non–small cell lung cancer.
Opinion
Enzalutamide in castration-sensitive prostate cancer and ctDNA to monitor early colorectal cancer
Dr. Lyss breaks down the results of the ARCHES trial and new data on ctDNA monitoring in early colorectal cancer.
Opinion
PROs in lung cancer and how to administer trastuzumab
Dr. Alan P. Lyss explains what the PACIFIC and HannaH trials mean for your day-to-day practice.
Opinion
Lessons from KEYNOTE-158 and the role of R-CHOP
Dr. Alan P. Lyss breaks down the clinical relevance of two recent studies in advanced cervical cancer and diffuse large B-cell lymphoma.
Opinion
Anastrozole-fulvestrant in breast cancer and daily aspirin to prevent HCC
In “How I will treat my next patient,” Dr. Alan P. Lyss analyzes the latest literature and breaks down what it means for everyday practice.